All Clinical Trials in Canada

A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Improving Patient Mental Health With Psychotherapist Virtual Training

NCT07087730

Recruiting

Several types of psychotherapy are equally effective to treat mental disorders. However, many patients remain symptomatic after treatment. The investigators demonstrated that a professional development training program to improve psychotherapists' skills at identifying and repairing therapeutic alliance tensions resulted in improved therapeutic alliance (an important therapeutic ingredient) and patient mental health outcomes. However, the investigators delivered this training program by conventional in-person workshops which limited access by psychotherapists living outside large urban centres. Further, post-study interviews with therapists suggested that cultural/diversity factors complicated the therapeutic alliance. In the current study, the investigators will test the effectiveness and acceptability of a virtually-delivered training program to psychotherapists in North America to improve their capacity to identify and repair problems in the therapeutic alliance, including tensions related to patient diversity. The investigators will also examine how acceptable the virtually-delivered training is to psychotherapists and whether they would use such training in their practice. Participants in the study will be community-based licensed psychotherapists and their patients engaging in therapy in North America. Patient mental health outcomes, therapeutic alliance, and diversity issues will be assessed by comparing outcome measures between three groups: 1) therapists complete a self-paced virtual course + consultation, 2) therapists complete synchronous workshop + consultation, 3) control: therapists do not complete training. The team of investigators developed Canada's largest psychotherapy practice-research network and has expertise in clinical trials, diversity, and education research of virtual training. State of the art training is often out of the reach of therapists who live outside of urban centres, and the effectiveness and acceptability of providing training virtually is not well-studied in mental health care. This study will improve psychotherapists' effectiveness at managing the therapeutic alliance and issues related to diversity, and will improve patient mental health outcomes thus promising to reduce the burden of mental illness. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: University of Ottawa, Ottawa, Ontario

Conditions: Mental Disorders

Learn More ›

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

NCT05835310

Recruiting

A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE

Gender:

ALL

Ages:

Between 5 years and 17 years

Trial Updated:

07/18/2025

Locations: Research Site, Phoenix, Arizona +91 locations

Research Site, Phoenix, Arizona

Research Site, Los Angeles, California

Research Site, Washington, District of Columbia

Research Site, Chicago, Illinois

Research Site, Bethesda, Maryland

Research Site, Saint Paul, Minnesota

Research Site, Bronx, New York

Research Site, New Hyde Park, New York

Research Site, New York, New York

Research Site, Valhalla, New York

Research Site, Durham, North Carolina

Research Site, Cincinnati, Ohio

Research Site, Cleveland, Ohio

Research Site, Columbus, Ohio

Research Site, Portland, Oregon

Research Site, Philadelphia, Pennsylvania

Research Site, Greenville, South Carolina

Research Site, El Paso, Texas

Research Site, Houston, Texas

Research Site, Salt Lake City, Utah

Research Site, Buenos Aires, Not set

Research Site, Córdoba, Not set

Research Site, Rosario, Not set

Research Site, Botucatu, Not set

Research Site, Curitiba, Not set

Research Site, Porto Alegre, Not set

Research Site, Ribeirão Preto, Not set

Research Site, Sao Paulo, Not set

Research Site, São Paulo, Not set

Research Site, Vancouver, British Columbia

Research Site, Toronto, Ontario

Research Site, Beijing, Not set

Research Site, Changchun, Not set

Research Site, Changsha, Not set

Research Site, Shanghai, Not set

Research Site, Suzhou, Not set

Research Site, Wenzhou, Not set

Research Site, Zhengzhou, Not set

Research Site, Barranquilla, Not set

Research Site, Medellin, Not set

Research Site, Bordeaux, Not set

Research Site, Bron, Not set

Research Site, Le Kremlin-Bicêtre, Not set

Research Site, LILLE Cedex, Not set

Research Site, Toulouse, Not set

Research Site, Berlin, Not set

Research Site, Freiburg, Not set

Research Site, Sankt Augustin, Not set

Research Site, Genova, Not set

Research Site, Milano, Not set

Research Site, Padova, Not set

Research Site, Roma, Not set

Research Site, Bunkyo-ku, Not set

Research Site, Chiba, Not set

Research Site, Fuchu-shi, Not set

Research Site, Kawasaki-shi, Not set

Research Site, Kobe-shi, Not set

Research Site, Obu-shi, Not set

Research Site, Shinjuku-ku, Not set

Research Site, Yokohama-shi, Not set

Research Site, Guadalajara, Not set

Research Site, Merida, Not set

Research Site, Mexico, Not set

Research Site, Monterrey, Not set

Research Site, Toluca, Not set

Research Site, Lodź, Not set

Research Site, Warszawa, Not set

Research Site, Wroclaw, Not set

Research Site, Lisboa, Not set

Research Site, Porto, Not set

Research Site, Cape Town, Not set

Research Site, Esplugues de Llobregat, Not set

Research Site, Madrid, Not set

Research Site, Málaga, Not set

Research Site, Valencia, Not set

Research Site, Ankara, Not set

Research Site, İstanbul, Not set

Research Site, Kayseri, Not set

Research Site, Umraniye, Not set

Research Site, Birmingham, Not set

Research Site, Bristol, Not set

Research Site, Liverpool, Not set

Research Site, London, Not set

Research Site, Manchester, Not set

Research Site, Southampton, Not set

Conditions: Systemic Lupus Erythematosus

Learn More ›

MagDI Canada Study

NCT06467955

Recruiting

The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

07/18/2025

Locations: University of Toronto, Toronto, Ontario +2 locations

Conditions: Obesity, Type 2 Diabetes

Learn More ›

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT06395103

Recruiting

Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab vedotin in pediatric participants with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL)/Burkitt lymphoma, or neuroblastoma and in pediatric and young adult participants with Ewing sarcoma.

Gender:

ALL

Ages:

Between 6 months and 25 years

Trial Updated:

07/18/2025

Locations: Children's Hospital Los Angeles ( Site 1006), Los Angeles, California +56 locations

Children's Hospital Los Angeles ( Site 1006), Los Angeles, California

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora, Colorado

Yale-New Haven Hospital ( Site 1012), New Haven, Connecticut

Johns Hopkins All Children's Hospital ( Site 1025), Saint Petersburg, Florida

University of Iowa-Holden Comprehensive Cancer Center ( Site 1017), Iowa City, Iowa

Dana-Farber Cancer Institute ( Site 1013), Boston, Massachusetts

Corewell Health ( Site 1001), Grand Rapids, Michigan

Children's Mercy Hospital ( Site 1024), Kansas City, Missouri

Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick, New Jersey

New York Medical College ( Site 1023), Valhalla, New York

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo, North Dakota

Oregon Health and Science University ( Site 1004), Portland, Oregon

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia, Pennsylvania

Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls, South Dakota

University of Texas MD Anderson Cancer Center ( Site 1007), Houston, Texas

Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City, Utah

Sydney Children's Hospital-Kids Cancer Centre ( Site 1997), Randwick, New South Wales

Queensland Children's Hospital-Oncology & Haematology ( Site 1996), Brisbane, Queensland

UZ Gent ( Site 1428), Gent, Oost-Vlaanderen

Hospital Erasto Gaertner-CEPEP - Pesquisa Clínica ( Site 1268), Curitiba, Parana

Hospital de Clinicas de Porto Alegre ( Site 1265), Porto Alegre, Rio Grande Do Sul

Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1264), Barretos, Sao Paulo

Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site 1267), São José do Rio Preto, Sao Paulo

McGill University Health Centre-Pediatric HematologyOncology ( Site 1223), Montréal, Quebec

Hospital Carlos Van Buren ( Site 1880), Valparaíso, Valparaiso

Hospital Pablo Tobon Uribe ( Site 1923), Medellin, Antioquia

Clinica de la Costa S.A.S.-Clinical Research Oncology & Hematology -Pediatric ( Site 1924), Barranquilla, Atlantico

IMAT S.A.S ( Site 1921), Monteria, Cordoba

Rigshospitalet-Department of paediatrics and adolescent medicine, Section of Paed haem-onc ( Site 1467), Copenhagen, Hovedstaden

CHU de Bordeaux. Hopital Pellegrin ( Site 1105), Bordeaux, Aquitaine

Gustave Roussy ( Site 1103), Villejuif, Ile-de-France

Centre Hospitalier Universitaire de Nantes - Hôpital Femme-Enfant-Adolescent Chu De Nantes ( Site 1104), Nantes, Pays-de-la-Loire

Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone ( Site 1102), Marseille, Provence-Alpes-Cote-d Azur

CENTRE LEON BERARD-IHOPE (pediatrric oncology) ( Site 1100), Lyon, Rhone-Alpes

Universitätsklinikum Münster - Albert Schweitzer Campus-Pädiatrische Hämatologie und Onkologie ( Site 1141), Münster, Nordrhein-Westfalen

Aghia Sophia Children's Hospital-First Department of Pediatrics, National and Kapodistrian Universi ( Site 1797), Athens, Attiki

Semmelweis Egyetem ( Site 1838), Budapest, Not set

Rambam Health Care Campus-Pediatric Hemato-Oncology ( Site 1674), Haifa, Not set

Sheba Medical Center ( Site 1675), Ramat Gan, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori-Pediatric Oncology ( Site 1552), Milan, Lombardia

Ospedale Pediatrico Bambino Gesù IRCCS-Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica ( Site 1553), Rome, Roma

Seoul National University Hospital-Pediatrics ( Site 1972), Seoul, Not set

Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 1973), Seoul, Not set

Prinses Maxima Centrum voor Kinderoncologie ( Site 1510), Utrecht, Not set

Narodny ustav detskych chorob ( Site 1592), Bratislava, Bratislavsky Kraj

Hospital Sant Joan de Déu-Pediatric Oncology Department ( Site 1717), Esplugas De Llobregat, Barcelona

Hospital Infantil Universitario Niño Jesús-Servicio de Onco-Hematología Pediátrica ( Site 1715), Madrid, Madrid, Comunidad De

Hospital Universitari Vall d'Hebron-Servei de Hematologia i Oncologia Pediatrica ( Site 1716), Barcelona, Not set

Prövningsenhet barn, Sahlgrenska Universitetssjukhuset ( Site 1634), Gothenburg, Vastra Gotalands Lan

National Taiwan University Hospital ( Site 1983), Taipei, Not set

Hacettepe Universite Hastaneleri ( Site 1961), Ankara, Not set

Ankara Bilkent Şehir Hastanesi ( Site 1962), Ankara, Not set

Ege Universitesi Hastanesi ( Site 1963), İzmir, Not set

Royal Victoria Infirmary-Great North Children's Hospital ( Site 1348), Newcastle upon Tyne, England

University College London Hospital ( Site 1350), London, London, City Of

Royal Marsden Hospital (Sutton)-Drug Development Unit ( Site 1347), Sutton., Surrey

University Hospital of Wales ( Site 1346), Cardiff, Not set

Conditions: B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma, Ewing Sarcoma

Learn More ›

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

NCT06112379

Recruiting

This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: Research Site, Daphne, Alabama +355 locations

Research Site, Daphne, Alabama

Research Site, Goodyear, Arizona

Research Site, Phoenix, Arizona

Research Site, Tucson, Arizona

Research Site, Jonesboro, Arkansas

Research Site, Rogers, Arkansas

Research Site, Bakersfield, California

Research Site, Fullerton, California

Research Site, Irvine, California

Research Site, Los Angeles, California

Research Site, Newport Beach, California

Research Site, Orange, California

Research Site, Santa Barbara, California

Research Site, Santa Rosa, California

Research Site, Sylmar, California

Research Site, Torrance, California

Research Site, Van Nuys, California

Research Site, Aurora, Colorado

Research Site, Fort Collins, Colorado

Research Site, Longmont, Colorado

Research Site, Bridgeport, Connecticut

Research Site, New Haven, Connecticut

Research Site, Newark, Delaware

Research Site, Fort Myers, Florida

Research Site, Jacksonville, Florida

Research Site, Port Saint Lucie, Florida

Research Site, Saint Petersburg, Florida

Research Site, Tallahassee, Florida

Research Site, West Palm Beach, Florida

Research Site, Atlanta, Georgia

Research Site, Chicago Ridge, Illinois

Research Site, Dyer, Indiana

Research Site, Des Moines, Iowa

Research Site, Edgewood, Kentucky

Research Site, Louisville, Kentucky

Research Site, Baton Rouge, Louisiana

Research Site, Annapolis, Maryland

Research Site, Boston, Massachusetts

Research Site, Detroit, Michigan

Research Site, Grand Rapids, Michigan

Research Site, Traverse City, Michigan

Research Site, Burnsville, Minnesota

Research Site, Minneapolis, Minnesota

Research Site, Columbia, Missouri

Research Site, Saint Louis, Missouri

Research Site, Omaha, Nebraska

Research Site, Henderson, Nevada

Research Site, Camden, New Jersey

Research Site, East Brunswick, New Jersey

Research Site, New Brunswick, New Jersey

Research Site, Santa Fe, New Mexico

Research Site, Commack, New York

Research Site, New York, New York

Research Site, Charlotte, North Carolina

Research Site, Durham, North Carolina

Research Site, Winston-Salem, North Carolina

Research Site, Blue Ash, Ohio

Research Site, Canton, Ohio

Research Site, Eugene, Oregon

Research Site, Portland, Oregon

Research Site, Horsham, Pennsylvania

Research Site, Philadelphia, Pennsylvania

Research Site, Pittsburgh, Pennsylvania

Research Site, Providence, Rhode Island

Research Site, Chattanooga, Tennessee

Research Site, Nashville, Tennessee

Research Site, Austin, Texas

Research Site, Dallas, Texas

Research Site, El Paso, Texas

Research Site, Flower Mound, Texas

Research Site, Fort Worth, Texas

Research Site, Houston, Texas

Research Site, Irving, Texas

Research Site, San Antonio, Texas

Research Site, Webster, Texas

Research Site, Fairfax, Virginia

Research Site, Norfolk, Virginia

Research Site, Richmond, Virginia

Research Site, Roanoke, Virginia

Research Site, Winchester, Virginia

Research Site, Tacoma, Washington

Research Site, Madison, Wisconsin

Research Site, Darlinghurst, Not set

Research Site, East Melbourne, Not set

Research Site, Heidelberg, Not set

Research Site, Herston, Not set

Research Site, Nedlands, Not set

Research Site, Waratah, Not set

Research Site, Feldkirch, Not set

Research Site, Graz, Not set

Research Site, Innsbruck, Not set

Research Site, Linz, Not set

Research Site, Salzburg, Not set

Research Site, Antwerpen, Not set

Research Site, Brasschaat, Not set

Research Site, Charleroi, Not set

Research Site, Gent, Not set

Research Site, Leuven, Not set

Research Site, Libramont-Chevigny, Not set

Research Site, Brasilia, Not set

Research Site, Curitiba, Not set

Research Site, Fortaleza, Not set

Research Site, Londrina, Not set

Research Site, Natal, Not set

Research Site, Porto Alegre, Not set

Research Site, Ribeirão Preto, Not set

Research Site, Santo Andre, Not set

Research Site, São Paulo, Not set

Research Site, Taubaté, Not set

Research Site, Vitória, Not set

Research Site, Plovdiv, Not set

Research Site, Shumen, Not set

Research Site, Sofia, Not set

Research Site, Vratza, Not set

Research Site, Calgary, Alberta

Research Site, Abbotsford, British Columbia

Research Site, Vancouver, British Columbia

Research Site, St. John's, Newfoundland and Labrador

Research Site, Barrie, Ontario

Research Site, London, Ontario

Research Site, Oshawa, Ontario

Research Site, Toronto, Ontario

Research Site, Levis, Quebec

Research Site, Montreal, Quebec

Research Site, Sherbrooke, Quebec

Research Site, St-Jerome, Quebec

Research Site, Saskatoon, Saskatchewan

Research Site, Montreal, Not set

Research Site, Ottawa, Not set

Research Site, Beijing, Not set

Research Site, Bengbu, Not set

Research Site, Changchun, Not set

Research Site, Changsha, Not set

Research Site, Chengdu, Not set

Research Site, Chongqing, Not set

Research Site, Guangzhou, Not set

Research Site, Hangzhou, Not set

Research Site, Harbin, Not set

Research Site, Hefei, Not set

Research Site, Jinan, Not set

Research Site, Kunming, Not set

Research Site, Linhai, Not set

Research Site, Nanchang, Not set

Research Site, Nanjing, Not set

Research Site, Nanning, Not set

Research Site, Shanghai, Not set

Research Site, Shenyang, Not set

Research Site, Shijiazhuang, Not set

Research Site, Suining, Not set

Research Site, Suzhou, Not set

Research Site, Tianjin, Not set

Research Site, Urumqi, Not set

Research Site, Wuhan, Not set

Research Site, Xi'an, Not set

Research Site, Xintai, Not set

Research Site, Zhaoqing, Not set

Research Site, Zhengzhou, Not set

Research Site, Avignon, Not set

Research Site, Bayonne, Not set

Research Site, Caen Cedex 5, Not set

Research Site, Clermont Ferrand, Not set

Research Site, Limoges, Not set

Research Site, Lyon, Not set

Research Site, Marseille, Not set

Research Site, Montpellier, Not set

Research Site, Nice, Not set

Research Site, Paris, Not set

Research Site, Reims Cedex, Not set

Research Site, Saint Herblain, Not set

Research Site, Toulouse, Not set

Research Site, Vandoeuvre les Nancy, Not set

Research Site, Villejuif Cedex, Not set

Research Site, Augsburg, Not set

Research Site, Berlin, Not set

Research Site, Dessau-Roßlau, Not set

Research Site, Dresden, Not set

Research Site, Erlangen, Not set

Research Site, Essen, Not set

Research Site, Esslingen am Neckar, Not set

Research Site, Frankfurt am Main, Not set

Research Site, Freiburg, Not set

Research Site, Hamburg, Not set

Research Site, Hannover, Not set

Research Site, Heidelberg, Not set

Research Site, Kiel, Not set

Research Site, Mainz, Not set

Research Site, Mannheim, Not set

Research Site, München, Not set

Research Site, Münster, Not set

Research Site, Trier, Not set

Research Site, Ulm, Not set

Research Site, Hong Kong, Not set

Research Site, Kwai Chung, Not set

Research Site, Budapest, Not set

Research Site, Kecskemét, Not set

Research Site, Miskolc, Not set

Research Site, Nyíregyháza, Not set

Research Site, Salgótarján, Not set

Research Site, Szekszárd, Not set

Research Site, Bengaluru, Not set

Research Site, Dehradun, Not set

Research Site, Delhi, Not set

Research Site, Kolkata, Not set

Research Site, Marg Jaipur, Not set

Research Site, Nagpur, Not set

Research Site, Nashik, Not set

Research Site, Puducherry, Not set

Research Site, Thiruvananthapuram, Not set

Research Site, Vadodara, Not set

Research Site, Empoli, Not set

Research Site, Lucca, Not set

Research Site, Macerata, Not set

Research Site, Milano, Not set

Research Site, Modena, Not set

Research Site, Napoli, Not set

Research Site, Padova, Not set

Research Site, Roma, Not set

Research Site, Rozzano, Not set

Research Site, Torino, Not set

Research Site, Tricase, Not set

Research Site, Udine, Not set

Research Site, Akashi-shi, Not set

Research Site, Akita-shi, Not set

Research Site, Bunkyo-ku, Not set

Research Site, Chiba-shi, Not set

Research Site, Chuo-ku, Not set

Research Site, Fukuoka-shi, Not set

Research Site, Fukushima-shi, Not set

Research Site, Gifu-shi, Not set

Research Site, Hidaka-shi, Not set

Research Site, Hirakata-shi, Not set

Research Site, Hiroshima-shi, Not set

Research Site, Isehara-shi, Not set

Research Site, Kashiwa, Not set

Research Site, Koto-ku, Not set

Research Site, Kumamoto-shi, Not set

Research Site, Kurume-shi, Not set

Research Site, Kyoto-shi, Not set

Research Site, Matsuyama-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Niigata-shi, Not set

Research Site, Okayama, Not set

Research Site, Osaka-shi, Not set

Research Site, Sapporo-shi, Not set

Research Site, Sendai-shi, Not set

Research Site, Shinagawa-ku, Not set

Research Site, Shinjuku-ku, Not set

Research Site, Sunto-gun, Not set

Research Site, Tsu-shi, Not set

Research Site, Yokohama-shi, Not set

Research Site, Daegu, Not set

Research Site, Goyang-si, Not set

Research Site, Seongnam, Not set

Research Site, Seoul, Not set

Research Site, George Town, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Kuching, Not set

Research Site, Selangor, Not set

Research Site, Bialystok, Not set

Research Site, Bydgoszcz, Not set

Research Site, Gdańsk, Not set

Research Site, Gdynia, Not set

Research Site, Kraków, Not set

Research Site, Tomaszów Mazowiecki, Not set

Research Site, Warszawa, Not set

Research Site, Wroclaw, Not set

Research Site, Łódź, Not set

Research Site, Singapore, Not set

Research Site, Barcelona, Not set

Research Site, Granada, Not set

Research Site, Hospitalet deLlobregat, Not set

Research Site, Madrid, Not set

Research Site, Santiago de Compostela, Not set

Research Site, Sevilla, Not set

Research Site, Zaragoza, Not set

Research Site, Baden, Not set

Research Site, Basel, Not set

Research Site, Bern, Not set

Research Site, Frauenfeld, Not set

Research Site, Genolier, Not set

Research Site, Rennaz, Not set

Research Site, Changhua, Not set

Research Site, Kaohsiung, Not set

Research Site, Taichung, Not set

Research Site, Tainan, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Dusit, Not set

Research Site, Muang, Not set

Research Site, Songkhla, Not set

Research Site, Adapazari, Not set

Research Site, Ankara, Not set

Research Site, Istanbul, Not set

Research Site, Kayseri, Not set

Research Site, Samsun, Not set

Research Site, Birmingham, Not set

Research Site, Cardiff, Not set

Research Site, Edinburgh, Not set

Research Site, Guildford, Not set

Research Site, Lancaster, Not set

Research Site, London, Not set

Research Site, Northampton, Not set

Research Site, Oxford, Not set

Research Site, Taunton, Not set

Research Site, Hanoi, Not set

Research Site, Ho Chi Minh city, Not set

Research Site, Vinh, Not set

Conditions: Breast Cancer

Learn More ›

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Recruiting

The purpose of this study is to evaluate the safety and efficacy of nemtabrutinib (formerly ARQ 531) in participants with hematologic malignancies of chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and Waldenström's macroglobulinemia (WM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: Highlands Oncology Group ( Site 2728), Springdale, Arkansas +120 locations

Highlands Oncology Group ( Site 2728), Springdale, Arkansas

University of California San Diego Moores Cancer Center ( Site 2717), La Jolla, California

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724), Torrance, California

Colorado Blood Cancer Institute ( Site 2726), Denver, Colorado

The University of Louisville, James Graham Brown Cancer Center ( Site 2729), Louisville, Kentucky

Mayo Clinic - Rochester ( Site 2706), Rochester, Minnesota

Astera Cancer Care ( Site 2732), East Brunswick, New Jersey

John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704), Hackensack, New Jersey

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 2708), Fargo, North Dakota

UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas, Texas

Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane, Washington

Hospital Aleman ( Site 0102), Ciudad Autonoma de Buenos Aires, Buenos Aires

Centro de Educación Médica e Investigaciones Clínicas (CEMIC) ( Site 0103), Buenos Aires, Caba

Fundacion Estudios Clinicos ( Site 0112), Rosario, Santa Fe

FUNDALEU ( Site 0104), Caba, Not set

Hospital Privado Universitario de Córdoba ( Site 0107), Cordoba, Not set

Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0110), Mendoza, Not set

Nepean Hospital-Nepean Cancer Care Centre ( Site 0204), Sydney, New South Wales

Box Hill Hospital ( Site 0203), Box Hill, Victoria

Sir Charles Gairdner Hospital ( Site 0200), Nedlands, Western Australia

Hospital das Clinicas FMUSP-Pesquisa Clínica Hematologia ( Site 0303), São Paulo, Sao Paulo

Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0300), Rio de Janeiro, Not set

BP - A Beneficencia Portuguesa de São Paulo ( Site 0302), Sao Paulo, Not set

Hospital Paulistano - Amil Clinical Research ( Site 0311), Sao Paulo, Not set

Arthur J.E. Child Comprehensive Cancer Centre ( Site 0401), Calgary, Alberta

The Ottawa Hospital ( Site 0404), Ottawa, Ontario

Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0406), Toronto, Ontario

CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0403), Montreal, Quebec

Jewish General Hospital ( Site 0400), Montreal, Quebec

Anhui Provincial Hospital ( Site 2808), Hefei, Anhui

Peking University Third Hospital-Hematology ( Site 2827), Beijing, Beijing

The Second Affiliated Hospital of Chongqing Medical University ( Site 2825), Chongqing, Chongqing

Sun Yat-sen University Cancer Center-Internal Medicine ( Site 2824), Guangzhou, Guangdong

Guangxi Medical University - Liuzhou Renmin Hospital ( Site 2817), Liuzhou, Guangxi

Guangxi Medical University Affiliated Tumor Hospital ( Site 2814), Nanning, Guangxi

Henan Cancer Hospital-hematology department ( Site 2802), Zhengzhou, Henan

Wuhan Union Hospital ( Site 2816), Wuhan, Hubei

The Second Xiangya Hospital of Central South University ( Site 2820), Changsha, Hunan

Hunan Cancer Hospital ( Site 2822), Changsha, Hunan

Jiangsu Province Hospital ( Site 2823), Nanjing, Jiangsu

The Affiliated Hospital of Xuzhou Medical College ( Site 2818), Xuzhou, Jiangsu

The First Affiliated Hospital of Nanchang University ( Site 2815), Nanchang, Jiangxi

The First Hospital of Jilin University-Hematology ( Site 2803), Changchun, Jilin

Fudan University Shanghai Cancer Center ( Site 2801), Shanghai, Shanghai

Huashan Hospital, Fudan University ( Site 2821), Shanghai, Shanghai

West China Hospital Sichuan University ( Site 2810), Chengdu, Sichuan

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Unio ( Site 2800), Tianjin, Tianjin

The First Affiliated Hospital, Zhejiang University ( Site 2826), Hangzhou, Zhejiang

Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0600), Brno, Brno-mesto

Fakultni nemocnice Hradec Kralove ( Site 0601), Hradec Kralove, Not set

Aarhus University Hospital ( Site 0702), Aarhus N, Midtjylland

Aalborg Universitetshospital ( Site 0703), Aalborg, Nordjylland

Sjaellands Universitetshospital Roskilde ( Site 0701), Roskilde, Sjaelland

Odense University Hospital ( Site 0705), Odense C, Syddanmark

Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0810), Nice, Alpes-Maritimes

Institut Paoli-Calmettes ( Site 0803), Marseille, Bouches-du-Rhone

Centre Hospitalier Lyon-Sud ( Site 0804), Pierre Benite, Rhone-Alpes

Centre Hospitalier de Versailles ( Site 0809), Le Chesnay, Yvelines

Hopital Saint Louis ( Site 0805), Paris, Not set

Universitaetsklinikum Ulm. ( Site 0906), Ulm, Baden-Wurttemberg

Universitaetsklinikum Koeln ( Site 0901), Koeln, Nordrhein-Westfalen

St. Marien-Krankenhaus Siegen ( Site 0914), Siegen, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus ( Site 0902), Dresden, Sachsen

Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar ( Site 1202), Pecs, Baranya

Debreceni Egyetem Klinikai Kozpont ( Site 1201), Debrecen, Hajdu-Bihar

Szabolcs Szatmár Bereg Vármegyei Oktatókórház ( Site 1206), Nyiregyhaza, Szabolcs-Szatmar-Bereg

Orszagos Onkologiai Intezet ( Site 1200), Budapest, Not set

Beaumont Hospital ( Site 2900), Dublin, Not set

University Hospital Limerick ( Site 2903), Limerick, Not set

Ha Emek Medical Center ( Site 1305), Afula, Not set

Soroka Medical Center ( Site 1307), Beer-Sheva, Not set

Rambam Medical Center ( Site 1301), Haifa, Not set

Hadassah Ein Karem Jerusalem ( Site 1300), Jerusalem, Not set

Chaim Sheba Medical Center ( Site 1302), Ramat Gan, Not set

Kaplan Medical Center ( Site 1304), Rehovot, Not set

Sourasky Medical Center ( Site 1303), Tel Aviv, Not set

Istituto Tumori Giovanni Paolo II ( Site 1409), Bari, Not set

A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1400), Bologna, Not set

ASST Spedali Civili di Brescia ( Site 1408), Brescia, Not set

IRCCS Ospedale San Raffaele ( Site 1402), Milano, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1403), Napoli, Not set

Fondazione IRCCS Policlinico San Matteo ( Site 1407), Pavia, Not set

IRCCS - Arcispedale Santa Maria Nuova ( Site 1405), Reggio Emilia, Not set

Policlinico Umberto I ( Site 1404), Roma, Not set

Severance Hospital Yonsei University Health System ( Site 2201), Seoul, Not set

Samsung Medical Center ( Site 2200), Seoul, Not set

Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site 1606), Wroclaw, Dolnoslaskie

Pratia MCM Krakow ( Site 1601), Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1608), Warszawa, Mazowieckie

Szpital Wojewódzki w Opolu-Hematology Department ( Site 1607), Opole, Opolskie

Szpitale Pomorskie Sp. z o.o. ( Site 1600), Gdynia, Pomorskie

Spitalul Clinic Colțea ( Site 1805), București, Bucuresti

Ovidius Clinical Hospital ( Site 1804), Ovidiu, Constanta

Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 1802), Brasov, Not set

Institutul Regional de Oncologie Iasi ( Site 1801), Iasi, Not set

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 2000), Hospitalet de Llobregat, Barcelona

Hospital Universitario de Salamanca ( Site 2002), Salamanca, Castilla Y Leon

CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2005), A Coruña, La Coruna

Hospital General Universitario de Alicante ( Site 2007), Alicante, Not set

Hospital Universitari Vall d'Hebron ( Site 2001), Barcelona, Not set

Hospital Universitario 12 de Octubre ( Site 2003), Madrid, Not set

Inselspital Bern ( Site 2303), Bern, Berne

Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 2302), Bellinzona, Ticino

Mega Medipol-Hematology ( Site 2406), Stanbul, Istanbul

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi ( Site 2400), Ankara, Not set

VKV Amerikan Hastanesi ( Site 2403), Istanbul, Not set

Sisli Florence Nightingale Hastanesi ( Site 2407), Istanbul, Not set

Dokuz Eylül Üniversitesi-Hematology ( Site 2402), Izmir, Not set

MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2509), Cherkassy, Cherkaska Oblast

Communal non-profit enterprise "Regional clinical hospital o-Hematology Department ( Site 2510), Ivano-Frankivsk, Ivano-Frankivska Oblast

Instit. of Blood Transfusion Medicine of the National Academy ( Site 2506), Lviv, Lvivska Oblast

National Cancer Institute ( Site 2507), Kyiv, Not set

Kyiv City Clinical Hospital 9 ( Site 2502), Kyiv, Not set

Bristol Haematology and Oncology Centre ( Site 2610), Bristol, Bristol, City Of

Nottingham University Hospitals NHS Trust. City Hospital Campus ( Site 2601), Nottingham, England

GenesisCare - Windsor ( Site 2608), Windsor, England

Sarah Cannon Research Institute UK ( Site 2612), London, London, City Of

GenesisCare - Oxford ( Site 2607), Oxford, Oxfordshire

GenesisCare - Cambridge ( Site 2611), Newmarket, Suffolk

The Royal Marsden NHS Foundation Trust. ( Site 2606), Sutton, Surrey

The Christie NHS Foundation Trust ( Site 2602), Manchester, Not set

Conditions: Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia

Learn More ›

Spatial Memory Training and Cognitive Function

NCT07002996

Recruiting

Mild cognitive impairment (MCI) is often considered a transitional stage between normal aging and dementia, particularly Alzheimer's disease (AD). Patients with MCI have subjective memory complaints corroborated by standard neuropsychological tests but remain functionally autonomous. One of the first brain regions to show AD pathology is the hippocampus (HPC). Reduction in HPC volume is a strong predictor of AD dementia. Therefore, improvement or restoration of HPC structure and function is thus... Read More

Gender:

ALL

Ages:

55 years and above

Trial Updated:

07/18/2025

Locations: Douglas Mental Health University Institute, Verdun, Quebec

Conditions: Mild Cognitive Impairment

Learn More ›

Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis

NCT06506474

Recruiting

Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. In pediatrics, investigations or treatments can be unpleasant or traumatizing to the child, can prolong the time spent in hospital, and can create a cascade of further futile investigations and treatments. Several of the commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics. The purpose of CareBEST is to study the use of 6 low-value healthcare services in children aged 1 to 12 months hospitalized with bronchiolitis, their costs, and measure the variability in practice of these services. The main questions this study aims to answer are: 1. How frequently are 6 low-value care health services used in children hospitalized with bronchiolitis? These 6 low-value care health services are: 1) respiratory virus testing; 2) chest x-rays; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics. * Are there factors that predict the use of these services? * What are the costs of the use of these services? 2. How much variability is there between different patients, different doctors, and between hospitals in the use of these 6 low-value health services ? 3. Are differences in use of low-value health services associated with patient and family characteristics (like race and ethnicity, socioeconomic status, language), and do these contribute to disparities in care? Participants will have their infant's medical chart reviewed during their hospitalization. They will also have 2 short questionnaires to complete, once during their child's admission to the hospital, and one 30 days later to ask about whether their child required any additional medical care. They will additionally be asked to complete a questionnaire on their perceptions regarding their child's care while hospitalized, including the use of shared-decision making and their understanding of and involvement in the care decisions made. This analysis will provide a better understanding of treatment of bronchiolitis in Canada and help in the development of effective interventions to reduce low-value care. Read Less

Gender:

ALL

Ages:

Between 28 days and 12 months

Trial Updated:

07/18/2025

Locations: Alberta Children's Hospital, Calgary, Alberta +14 locations

Conditions: Bronchiolitis

Learn More ›

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

NCT06690775

Recruiting

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: SCRI - Arizona Oncology Associates, PC-HOPE, Tucson, Arizona +27 locations

SCRI - Arizona Oncology Associates, PC-HOPE, Tucson, Arizona

City of Hope National Medical Center, Duarte, California

UCLA - JCCC Clinical Research Unit, Los Angeles, California

SCRI - Sansum Clinic, Santa Barbara, California

Smilow Cancer Hsopital at Yale - New Haven, New Haven, Connecticut

SCRI - Maryland Oncology Hematology, P.A., Annapolis, Maryland

Massachusetts General Hospital, Boston, Massachusetts

SCRI - Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota

University of Minnesota, Minneapolis, Minnesota

Washington University, Saint Louis, Missouri

The James Cancer Hospital and Solove Research Institute - Ohio State University, Columbus, Ohio

Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, Oklahoma

SCRI - Northwest Cancer Specialists, P.C., Portland, Oregon

SCRI - Alliance Cancer Specialists, PC, Doylestown, Pennsylvania

University of Pennsylvania, Philadelphia, Pennsylvania

SCRI - Texas Oncology, Fort Worth, Texas

SCRI - Virginia Oncology Associates, Norfolk, Virginia

Monash Medical Centre, Clayton, Melbourne

Icon Cancer Centre Chermside, Chermside, Queensland

Linear Clinical Research, Perth, Western Australia

British Columbia Cancer Agency (BC Cancer, part of the Provincial Health Services Authority), Vancouver, British Columbia

Sunnybrook Health Sciences Centre, Toronto, Ontario

Princess Margaret Cancer Centre - University Health Network (UHN), Toronto, Ontario

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec

Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec

McGill University Health Centre (MUHC) - Royal Victoria Hospital, Montreal, Quebec

National University Cancer Institute, Singapore, Not set

National Cancer Centre, Singapore, Not set

Conditions: Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer

Learn More ›

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

NCT04938817

Recruiting

This study is a rolling arm study of investigational agents as monotherapy or in combination with pembrolizumab in participants with anti-programmed cell death 1 (PD-1)/ programmed cell death ligand 1 (PD-L1) refractory ES-SCLC in need of second-line treatment. This study will have 2 parts: an initial safety lead-in to determine safety and tolerability for experimental combinations of investigational agents without an established recommended phase 2 dose (RP2D) followed by an efficacy evaluation... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: Banner MD Anderson Cancer Center ( Site 0152), Gilbert, Arizona +47 locations

Banner MD Anderson Cancer Center ( Site 0152), Gilbert, Arizona

Northside Hospital-Northside Hospital Oncology Network ( Site 0156), Atlanta, Georgia

Parkview Research Center at Parkview Regional Medical Center ( Site 0180), Fort Wayne, Indiana

Baptist Health Lexington-Research ( Site 0158), Lexington, Kentucky

University of Kentucky Chandler Medical Center-Medical Oncology ( Site 0157), Lexington, Kentucky

MFSMC-HJWCI-Oncology Research ( Site 0178), Baltimore, Maryland

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0172), Omaha, Nebraska

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0179), Omaha, Nebraska

Cleveland Clinic-Taussig Cancer Center ( Site 0166), Cleveland, Ohio

UPMC Hillman Cancer Center ( Site 0177), Pittsburgh, Pennsylvania

St Francis Cancer Center-Research Office ( Site 0167), Greenville, South Carolina

Virginia Cancer Institute ( Site 0169), Richmond, Virginia

Westmead Hospital-Department of Medical Oncology ( Site 4004), Westmead, New South Wales

The Prince Charles Hospital-Oncology Clinical Trials ( Site 4003), Brisbane, Queensland

Monash Health-Oncology Research ( Site 4005), Clayton, Victoria

Hollywood Private Hospital-Medical Oncology ( Site 4001), Perth, Western Australia

Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 3101), Wien, Not set

Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 3100), Wien, Not set

Cross Cancer Institute ( Site 3004), Edmonton, Alberta

Princess Margaret Cancer Centre ( Site 3003), Toronto, Ontario

St. Marys Hospital Center ( Site 3000), Montreal, Quebec

Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 3800), Szolnok, Jasz-Nagykun-Szolnok

Rambam Health Care Campus-Oncology ( Site 3600), Haifa, Not set

Shaare Zedek Medical Center-Oncology ( Site 3602), Jerusalem, Not set

Meir Medical Center. ( Site 3601), Kfar Saba, Not set

Rabin Medical Center-Oncology ( Site 3604), Petah Tikva, Not set

Sheba Medical Center-ONCOLOGY ( Site 3603), Ramat Gan, Not set

Humanitas-U.O di Oncologia medica ed Ematologia ( Site 3301), Rozzano, Milano

ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 3300), Siena, Toscana

Ospedale San Raffaele-Oncologia Medica ( Site 3303), Milano, Not set

Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 3304), Milano, Not set

Chungbuk National University Hospital ( Site 4106), Cheongju-si, Chungbuk

Seoul National University Bundang Hospital-Medical Oncology ( Site 4104), Seongnam, Kyonggi-do

Seoul National University Hospital ( Site 4101), Seoul, Not set

Asan Medical Center-Lung Cancer Center ( Site 4103), Seoul, Not set

Samsung Medical Center ( Site 4100), Seoul, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 3900), Warszawa, Mazowieckie

Warminsko-Mazurskie Centrum Chorob Płuc w Olsztynie ( Site 3903), Olsztyn, Warminsko-mazurskie

Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 3708), Krasnoyarsk, Krasnoyarskiy Kray

Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 3702), Saint Petersburg, Leningradskaya Oblast

N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( Site 3703), Saint Petersburg, Sankt-Peterburg

GBUZ LOKB-Oncology department #1 ( Site 3701), Saint-Petersburg, Sankt-Peterburg

GBUZ "SPb CRPCstmc(o)" ( Site 3705), Saint-Petersburg, Sankt-Peterburg

Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 3704), Sankt-Peterburg, Not set

Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 3403), L'Hospitalet de Llobregat, Cataluna

Hospital Universitari Vall d'Hebron-Oncology ( Site 3401), Barcelona, Not set

Hospital Clinic de Barcelona ( Site 3404), Barcelona, Not set

Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502), St.Gallen, Sankt Gallen

Conditions: Small Cell Lung Carcinoma

Learn More ›

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

NCT06073457

Recruiting

The purpose of this clinical research study is to evaluate the feasibility of the GT Metabolic Solutions Magnet System, GJ Biofragmentable ("MagGJ System") for creation of a side-to-side anastomosis for gastro-ileal or gastro-jejunal diversion in obese adults.

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

07/18/2025

Locations: Westmount Surgical Center, Westmount, Quebec +2 locations

Conditions: Obesity, Type 2 Diabetes

Learn More ›

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

NCT06830759

Recruiting

Diffuse large B-cell lymphoma (DLBCL) is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections) and the most common type of non-Hodgkin lymphoma. Follicular Lymphoma (FL) is a slow-growing type of non-Hodgkin lymphoma. The purpose of this study is to assess the real-world effectiveness of subcutaneous epcoritamab in adult participants with advanced DLBCL and FL. Epcoritamab is an investigational drug being developed for treating particip... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: Hospital Privado Universitario De Córdoba /ID# 274457, Córdoba, Cordoba +25 locations

Hospital Privado Universitario De Córdoba /ID# 274457, Córdoba, Cordoba

Fundacion Argentina contra la Leucemia (FUNDALEU) /ID# 274390, Buenos Aires, Not set

Hospital Británico de Buenos Aires /ID# 274419, Buenos Aires, Not set

Krankenhaus Der Barmherzigen Brueder Graz /ID# 273288, Graz, Steiermark

Universitair Ziekenhuis Brussel /ID# 273403, Jette, Bruxelles-Capitale

Centre Hospitalier Epicura - site d'Hornu /ID# 273406, Boussu, Hainaut

Grand Hôpital De Charleroi - Notre Dame /ID# 273728, Charleroi, Hainaut

Helora /ID# 273726, La Louvière, Hainaut

Ziekenhuis Oost-Limburg, Campus St.-Jan /ID# 273729, Genk, Limburg

Vitaz /Id# 273408, Sint-Niklaas, Oost-Vlaanderen

Cross Cancer Institute /ID# 271504, Edmonton, Alberta

Health Sciences North /ID# 274738, Sudbury, Ontario

Evangelismos Hospital /ID# 272736, Athens, Attiki

General Hospital of Athens Laiko /ID# 272758, Athens, Attiki

Metaxa Cancer Hospital Of Piraeus /ID# 273623, Piraeus, Attiki

University General Hospital of Alexandroupoli /ID# 272737, Alexandroupoli, Evros

University Hospital of Ioannina /ID# 272739, Ioannina, Not set

Papageorgiou General Hospital /ID# 272735, Thessaloniki, Not set

General Hospital Of Thessaloniki G. Papanikolaou /ID# 275323, Thessaloniki, Not set

Tel Aviv Sourasky Medical Center /ID# 271615, Tel Aviv, Tel-Aviv

Rabin Medical Center /ID# 271614, Petah Tikva, Not set

Complejo Hospitalario Universitario A Coruña /ID# 272040, A Coruña, A Coruna

Hospital Universitario Reina Sofia /ID# 272051, Córdoba, Cordoba

Hospital Universitario de Valme /ID# 272050, Seville, Sevilla

Hospital de Manises /ID# 272046, Manises, Valencia

Hospital Universitario Nuestra Señora de Candelaria /ID# 272413, Santa Cruz de Tenerife, Not set

Conditions: Diffuse Large B-cell Lymphoma, Follicular Lymphoma

Learn More ›